Conventional blood banking and blood component storage regulation: Opportunities for improvement

Blood Transfusion

Volumn 8, Issue SUPPL. 3, 2010, Pages

  Hess, John R ^a  

^a UNIVERSITY OF MARYLAND   (United States)

Author keywords

Blood banking; Blood component; Storage; Transfusion

Indexed keywords

BLOOD BANK; BLOOD COMPONENT; BLOOD DONOR; BLOOD SAMPLING; BLOOD STORAGE; BLOOD TRANSFUSION; HEMOLYSIS; REVIEW; THROMBOCYTE PRESERVATION;

BLOOD BANKS; BLOOD COMPONENT TRANSFUSION; BLOOD PLATELETS; BLOOD PRESERVATION; CELL SEPARATION; ERYTHROCYTES; HUMANS; PLASMA;

EID: 78049404545     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2010.003S     Document Type: Review

References (40)

1. Collins JA. The surgeon's point of view. Pages 339-344 in: Chaplin H Jr, Jaffe ER, Lanfant C, Valeri CR. Preservation of red blood cells. Washington, DC: National Academy of Sciences, 1973.
2. AABB Standards.
3. Epstein J, Seitz R, Dhingra N, et al. Role of regulatory agencies. Biologicals 2009; 37(2): 94-102.
4. Dumont LJ, AuBuchon JP. Evaluation of proposed FDA criteria for the evaluation of radiolabeled red cell recovery trials. Transfusion 2008 Jun; 48(6): 1053-60.
5. Dumont LJ, AuBuchon JP, Gulliksson H, et al. In vitro pH effects on in vivo recovery and survival of platelets: an analysis by the BEST Collaborative. Transfusion 2006; 46(8): 1300-5.
6. Sullivan MT, Cotten R, Read EJ, Wallace EL. Blood collection and transfusion in the United States in 2001. Transfusion 2007; 47(3): 385-94.
7. Heaton WA, Rebulla P, Pappalettera M, Dzik WH. A comparative analysis of different methods for routine blood component preparation. Transfus Med Rev 1997; 11(2): 116-29. (Pubitemid 27202246)
8. Hess JR. An update on solutions for red cell storage. Vox Sang 2006; 91: 13-9.
9. de Korte D, Kleine M, Korsten HG, Verhoeven AJ. Prolonged maintenance of 2,3-diphosphoglycerate acid and adenosine triphosphate in red blood cells during storage. Transfusion 2008; 48(6): 1081-9.
10. Hess JR, Greenwalt TJ. Storage of red blood cells: New approaches. Transfus Med Rev 2002 Oct; 16: 283-95.
11. Moroff G, Sohmer PR, Button LN. Proposed standardization of methods for determining the 24-hour survival of stored red cells. Transfusion 1984; 24(2): 109-14.
12. Reid TJ, Babcock JG, Derse-Anthony CP, et al. The viability of autologous human red blood cells stored in additive solution-5 and exposed to 25°C for 24 hours. Transfusion 1999; 39: 991-7.
13. Vamvakas EC, Blajchman MA. Transfusion-related immunomodulation (TRIM): an update. Blood Rev 2007; 21(6): 327-48.
14. Vlaar AP, de Korte D, Juffermans NP. The aged erythrocyte: key player in cancer progression, but also in infectious and respiratory complications of blood transfusion? Anesthesiology 2009; 111(2): 444.
15. Hess JR. Red cell storage. J Proteomics 2010; 73:368-73.
16. D'Amici GM, Rinalducci S, Zolla L. Proteomic analysis of RBC membrane protein degradation during blood storage. J Proteome Res 2007; 6: 3242-55. (Pubitemid 47310209)
17. Greenwalt TJ, McGuinness CG, Dumaswala UJ. Studies in red blood cell preservation: 4. Plasma vesicle hemoglobin exceeds free hemoglobin. Vox Sang 1991; 61(1): 14-7.
18. Greenwalt TJ. The how and why of exocytic vesicles. Transfusion 2006; 46: 143-52.
19. Salzer U, Zhu R, Luten M, et al. Vesicles generated during storage of red cells are rich in the lipid raft marker stomatin. Transfusion 2008; 48: 451-62.
20. Hess JR, Sparrow RL, van der Meer P, et al. Red cell hemolysis during blood bank storage: using national quality management data to answer basic scientific questions. Transfusion 2009; 49: 2599-603.
21. Heaton WA, Holme S, Smith K, et al. Effects of 3-5 log10 pre-storage leucocyte depletion on red cell storage and metabolism. Br J Haematol 1994; 87(2): 363-8.
22. Gladwin MT, Kim-Shapiro DB. Storage lesion in banked blood due to hemolysis-dependent disruption of nitric oxide homeostasis. Curr Opin Hematol 2009; 16(6): 515-23.
23. Blajchman MA, Slichter SJ, Heddle NM, Murphy MF. New strategies for the optimal use of platelet transfusions. Hematology Am Soc Hematol Educ Program 2008: 198-204.
24. Heaton WA, Rebulla P, Pappalettera M, Dzik WH. A comparative analysis of different methods for routine blood component preparation. Transfus Med Rev 1997; 11(2): 116-29. (Pubitemid 27202246)
25. Dumont LJ, Gulliksson H, van der Meer PF, et al. Interruption of agitation of platelet concentrates: a multicenter in vitro study by the BEST Collaborative on the effects of shipping platelets. Transfusion 2007 Sep; 47(9): 1666-73.
26. Rumjantseva V, Hoffmeister KM. Novel and unexpected clearance mechanisms for cold platelets. Transfus Apher Sci 2010; 42(1): 63-70.
27. Murphy S. Platelet storage for transfusion. Semin Hematol 1985; 22(3): 165-77.
28. Moreau ME, Thibault L, Désormeaux A, et al. Generation of kinins during preparation and storage of whole blood-derived platelet concentrates. Transfusion 2007; 47(3): 410-20. (Pubitemid 46272481)
29. van der Meer PF, Kerkhoffs JL, Curvers J, et al. In vitro comparison of platelet storage in plasma and in four platelet additive solutions, and the effect of pathogen reduction: a proposal for an in vitro rating system. Vox Sang 2009 Nov 18. [Epub ahead of print]
30. Wagner SJ. Transfusion-transmitted bacterial infection: risks, sources and interventions. Vox Sang 2004; 86:157-63.
31. van der Meer PF, Pietersz RN, Reesink HW. Storage of platelets in additive solution for up to 12 days with maintenance of good in-vitro quality. Transfusion 2004; 44(8): 1204-11.
32. Thon JN, Schubert P, Devine DV. Platelet storage lesion: a new understanding from a proteomic perspective. Transfus Med Rev 2008; 22(4): 268-79.
33. Schubert P, Thon JN, Walsh GM, et al. A signaling pathway contributing to platelet storage lesion development: targeting PI3-kinase-dependent Rap1 activation slows storage-induced platelet deterioration. Transfusion 2009 Sep; 49(9): 1944-55.
34. AuBuchon JP, Herschel L, Roger J, Murphy S. Preliminary validation of a new standard of efficacy for stored platelets. Transfusion 2004; 44(1): 36-41. (Pubitemid 38177134)
35. Vamvakas EC, Blajchman MA. Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention. Blood 2009; 113(15): 3406-17.
36. Anderson NL. The Clinical Plasma Proteome: A Survey of Clinical Assays for Proteins in Plasma and Serum. Clin Chem 2009 Nov 2. [Epub ahead of print]
37. Kreutziger J, Schlaepfer J, Wenzel V, Constantinescu MA. The role of admission blood glucose in outcome prediction of surviving patients with multiple injuries. J Trauma 2009; 67(4): 704-8.
38. Douay L, Andreu G. Ex vivo production of human red blood cells from hematopoietic stem cells: what is the future in transfusion? Transfus Med Rev 2007; 21(2): 91-100.
39. Armand R, Hess JR. Treating coagulopathy in trauma patients. Transfus Med Rev 2003; 17: 223-31.
40. Shuja F, Shults C, Duggan M, et al. Development and testing of freeze-dried plasma for the treatment of trauma-associated coagulopathy. J Trauma 2008; 65(5): 975-85.